Andrea Spallarossa

24PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsClinical pharmacology and therapeuticsMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 29, 2025
USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis.

Matteo Lusardi, Federica Rapetti, Andrea Spallarossa

|Jul 12, 2025
Triazole-imidazo[1,2-<i>b</i>]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes.

Chiara Brullo, Barbara Marengo, Cinzia Domenicotti

|Aug 10, 2024
PDE4D: A Multipurpose Pharmacological Target.

Matteo Lusardi, Federica Rapetti, Andrea Spallarossa

|Jun 27, 2024
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells.

Erika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti

|May 25, 2024
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives.

Federica Rapetti, Andrea Spallarossa, Eleonora Russo

|May 11, 2024
Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.

Matteo Lusardi, Maria Grazia Signorello, Eleonora Russo

Pageof 4

Frequent Collaborators

16 joint publications

Chiara Brullo

11 joint publications

Matteo Lusardi

9 joint publications

Bruno Tasso

6 joint publications

Carla Villa